|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 07/15/07 | Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal | RE |
| 29/15/29 | Mylan NV : Exclusive - Perrigo expected to reject Mylan's latest offer | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | - | - | - | - | - | 0 | |
| +0.65% | -3.56% | -12.32% | +14.23% | +57.11% | +33.53% | +60.50% | +5.04% | - | 6.35TCr | |
| +1.76% | +1.27% | -5.68% | +3.19% | +11.13% | +11.82% | +81.21% | +231.09% | +5,462.85% | 5.45TCr | |
| -0.94% | +0.77% | +10.65% | +12.58% | +17.11% | +8.85% | +100.19% | -16.58% | +256.22% | 5.36TCr | |
| +2.76% | +0.87% | +2.98% | +14.86% | +23.79% | +27.92% | +55.07% | +8.50% | +288.80% | 4.48TCr | |
| +2.00% | -3.39% | +1.73% | +12.98% | +22.89% | +17.83% | +119.04% | +2.41% | +1,015.51% | 4.16TCr | |
| +1.34% | -2.86% | -6.45% | +2.64% | +136.94% | +224.43% | +914.08% | +534.35% | - | 3.99TCr | |
| +0.64% | -3.85% | +6.99% | +6.21% | +10.10% | +11.71% | +45.57% | +5.41% | +152.66% | 3.25TCr | |
| +29.06% | +48.65% | +69.87% | +102.73% | +90.82% | +106.84% | +92.73% | +33.20% | +238.70% | 2.67TCr | |
| +3.72% | -7.45% | -12.60% | +19.81% | +47.33% | +24.25% | -2.99% | -60.58% | - | 2.34TCr | |
| +1.07% | -3.61% | -11.19% | -4.82% | -7.57% | -16.22% | -3.52% | -69.02% | - | 2.19TCr | |
| +2.13% | +3.13% | -17.58% | -6.87% | -44.28% | -41.33% | +306.11% | +227.75% | +616.25% | 2.07TCr | |
| +2.80% | +4.56% | +12.46% | +21.32% | +23.33% | +19.32% | +176.76% | +215.27% | +2,297.65% | 1.88TCr | |
| +4.22% | +8.44% | +26.95% | +55.55% | +87.48% | +99.00% | +116.69% | -14.77% | +392.08% | 1.71TCr | |
| +0.89% | +6.60% | +9.55% | +25.86% | +38.21% | +41.38% | +86.34% | -16.19% | +110.21% | 1.65TCr | |
| +1.42% | +2.63% | +13.55% | +17.29% | +51.22% | +65.39% | +228.12% | +204.60% | +509.19% | 1.62TCr | |
| +1.50% | +4.46% | +8.48% | -1.92% | - | - | - | - | - | 1.61TCr | |
| +0.84% | +3.90% | +3.90% | +0.42% | +183.22% | +163.59% | +345.61% | +1,418.19% | +787.21% | 1.52TCr | |
| -4.32% | -7.35% | -7.15% | -15.56% | +10.56% | +0.93% | +463.48% | - | - | 1.38TCr | |
| +17.04% | +15.61% | +21.98% | +18.82% | +17.53% | +20.50% | -8.99% | -25.23% | +166.63% | 1.41TCr | |
| Average | +3.61% | +1.76% | +6.11% | +15.75% | +43.16% | +45.54% | +176.45% | +157.85% | +945.69% | 2.76TCr | |
| Weighted average by Cap. | +3.05% | +0.89% | +3.80% | +15.08% | +41.10% | +43.71% | +167.67% | +124.30% | +1,249.64% |
- Stock Market
- Stocks
- Stock
- Sector Pharmacyclics, Inc.
Select your edition
All financial news and data tailored to specific country editions
